Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER

Validity of sentinel lymph nodes biopsy after neoadjuvant chemotherapy in case of complete pathological response of axillary lymph nodes

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

Evaluation of targeted axillary dissection in node positive locally advanced breast cancer patients with complete pathological response to neoadjuvant chemotherapy

Evaluation of the technique of endoscopic axillary sentinel lymph node biopsy in early-stage node-negative breast cancer

Evaluation of conservative breast surgery after neoadjuvant chemotherapy in breast cancer

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

Can Sentinel Node Biopsy Continue to Be a Diagnostic Tool for Radiologically Negative Axilla in Early Breast Cancer?

Predictive value of axillary nodal mapping after neoadjuvant chemotherapy in breast cancer